Page last updated: 2024-09-02

landiolol and Endotoxin Shock

landiolol has been researched along with Endotoxin Shock in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Bion, J; Boota, N; Gates, S; Ghuman, B; Gordon, AC; Hill, M; Hossain, A; Innes, R; Lall, R; Lord, J; MacCallum, NS; McAuley, D; Mistry, D; Perkins, GD; Regan, SE; Singer, M; Skilton, E; Veenith, T; Welters, I; Whitehouse, T; Yeung, J; Young, D1
Bion, J; Boota, N; Gates, S; Gordon, AC; Lall, R; Lord, J; McAuley, DF; Mistry, D; Perkins, G; Regan, S; Singer, M; Skilton, E; Whitehouse, T; Young, D1
Arita, Y; Hasegawa, S; Segawa, T; Yamamoto, S1
Kawada, T; Li, M; Sugimachi, M; Uemura, K; Zheng, C1
Biancofiore, G; Bouvet, O; Cerny, V; Dostál, P; Girardis, M; Grohmann-Izay, B; Guarracino, F; Heinz, G; Joannidis, M; Kadlecova, P; Klade, C; Krejcy, K; Krumpl, G; Morelli, A; Pratesi, F; Radermacher, P; Rehberg, S; Siebers, C; Singer, M; Trimmel, H; Unger, M; Zörer, M1

Trials

2 trial(s) available for landiolol and Endotoxin Shock

ArticleYear
Study into the reversal of septic shock with landiolol (beta blockade): STRESS-L Study protocol for a randomised trial.
    BMJ open, 2021, 02-16, Volume: 11, Issue:2

    Topics: COVID-19; England; Humans; Morpholines; Randomized Controlled Trials as Topic; Shock, Septic; Treatment Outcome; Urea

2021
Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial.
    Trials, 2018, Nov-19, Volume: 19, Issue:1

    Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Blood Pressure; Clinical Trials, Phase IV as Topic; Europe; Heart Rate; Humans; Intensive Care Units; Morpholines; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Shock, Septic; Time Factors; Treatment Outcome; Urea; Vasoconstrictor Agents

2018

Other Studies

3 other study(ies) available for landiolol and Endotoxin Shock

ArticleYear
Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial.
    JAMA, 2023, 11-07, Volume: 330, Issue:17

    Topics: Adrenergic beta-Antagonists; Adult; Female; Humans; Male; Middle Aged; Norepinephrine; Sepsis; Shock, Septic; State Medicine; Tachycardia

2023
Landiolol is effective for the treatment of tachycardia-induced cardiogenic shock in patients during septic shock therapy.
    BMJ case reports, 2017, Nov-01, Volume: 2017

    Topics: Aged; Anti-Arrhythmia Agents; Diagnosis, Differential; Electrocardiography; Female; Humans; Morpholines; Shock, Cardiogenic; Shock, Septic; Tachycardia, Supraventricular; Urea

2017
Low-Dose Landiolol Reduces Heart Rate and Cardiac Oxygen Consumption Without Compromising Initial Hemodynamic Resuscitation in a Canine Model of Endotoxin Shock.
    Shock (Augusta, Ga.), 2019, Volume: 52, Issue:1

    Topics: Animals; Cardiac Output; Dogs; Female; Heart Rate; Hemodynamics; Male; Morpholines; Oxygen Consumption; Resuscitation; Shock, Septic; Urea

2019